Company news
Jiangsu gdk Biotechnology Co., Ltd. news in 2026
Jiangsu gdk Biotechnology Co., Ltd.'s news releases, calls and decks from 2026, newest first.
(688670)"JIANGSU GDK BIOLOGICAL TECHNOLOGY CO., LTD."Report for Q3 2026
October 30, 2026
(688670)"JIANGSU GDK BIOLOGICAL TECHNOLOGY CO., LTD."Notice on Convening the 1st Extraordinary General Meeting in 2026
October 30, 2026
(688670)"JIANGSU GDK BIOLOGICAL TECHNOLOGY CO., LTD."Announcement on Change of Certain Raised Funds Investment Project
October 30, 2026
(688670)"JIANGSU GDK BIOLOGICAL TECHNOLOGY CO., LTD."Announcement on Risk Warning Regarding the Receipt of a Drug Registration Certificate for the Company's Split Virion Influenza Vaccine and Uncertainty in Operating Performance
October 9, 2026
Announcement on Convening the 2026 Semi-annual Performance Briefing
September 9, 2026
Special Report on the Deposit, Management and Actual Use of Raised Funds for the First Half of 2026
August 20, 2026
Announcement on Renewal of Joint Control and Concerted Action Agreement by Controlling Shareholder and Joint Actual Controllers
August 3, 2026
Announcement on Reply to Regulatory Inquiry Letter Regarding Information Disclosure of 2025 Annual Report
June 7, 2026
Announcement on Resolutions of the 2025 Annual General Meeting
May 14, 2026
Notice on Convening the 2025 Annual General Meeting
April 22, 2026
Announcement on Resignation of Senior Management Member
March 20, 2026
Announcement on Preliminary Earnings Estimate for 2025
February 12, 2026
Earnings Preannouncement for 2025
January 30, 2026